A Massive Study of 250,000 Patients Just Revealed a Surprising New Use for GLP-1s
A new Mayo Clinic analysis of more than 250,000 health records reveals that GLP-1 drugs could outperform metformin in reversing prediabetes and lowering heart risks.
Original Source
Read the full article at Inc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.